US Patent Issued to SHANGHAI HUAYU BIOTECHNOLOGY on Aug. 25 for "Combination cancer therapy using CHK inhibitor" (Washington, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,707, issued on Aug. 25, was assigned to SHANGHAI HUAYU BIOTECHNOLOGY Co. LTD (Shanghai).

"Combination cancer therapy using CHK inhibitor" was invented by Fan Wu (Brookline, Mass.) and Zhanggui Wu (Brookline, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods for treating a cancer selected from breast cancer, colon cancer, ovarian cancer, or pancreatic cancer in a subject in need thereof, comprising administering a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof, in combination with a poly (ADP)-ribose polymerase (PARP) inhibitor. The compound of formula I acts as a che...